Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion type Assertion NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_head.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion description "[HER-2/neu-dependent differential expression of PGK1, FASN, Hsp27, and GLO was further validated in four breast cancer cell lines and 12 breast tumors by immunoblotting and confirmed by partially switching off the HER-2/neu signaling in the high HER-2/neu-expressing SKBr3 cell line with Herceptin treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_provenance.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion evidence source_evidence_literature NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_provenance.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion SIO_000772 16048908 NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_provenance.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion wasDerivedFrom befree-20140225 NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_provenance.
- NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_assertion wasGeneratedBy ECO_0000203 NP295352.RA_iGFD1sw7z2qrJ_9n96dr6kh6vuN2q_3oV0UWsFSS9Q130_provenance.